What can longer follow-up tell us about treatment in metastatic hormone-sensitive prostate cancer?

Live from #ESMO2026, Dr. Karim Fizazi joins Brian and Tom to discuss two presentations featuring long-term follow-up data in mHSPC and what these findings could mean for clinical practice.

🎙️ Episode 525 of The Uromigos Podcast is now live: https://bit.ly/4icoCmd

#Uromigos #ProstateCancer #GUOncology